MedTrace Logo

Fetal Brain Growth - Pilot Study

NCT05994443 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2023-08-16

No results posted yet for this study

Summary

The goal of this observational prospective study is to explore the feasibility of measuring fetal and neonatal brain growth using 2D and 3D ultrasound in fetuses exposed to threatened preterm labor (TPTL) and antenatal corticosteroids (ACS) compared to non-exposed fetuses.

Patients with singleton pregnancies on our site with repeated ultrasound measurements every 4 weeks will be evaluated for fetal brain development. The exposed group is defined as patients with a dual exposure of TPTL and ACS. The non-exposed group will be composed of patients who did not have TPTL and ACS. Therefore, patients will have a maximum of 5 additional visits (4 that will occur prenatally and 1 postnatal visit).

Conditions

  • Preterm Labor
  • Maternal Psychological Distress

Sponsors & Collaborators

  • McGill University

    collaborator OTHER

  • University of Arizona

    collaborator OTHER

  • McGill University Health Centre/Research Institute of the McGill University Health Centre

    lead OTHER

Principal Investigators

  • Anne-Maude Morency, MD · RI-MUHC

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-08
Primary Completion
2025-06-01
Completion
2025-12-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05994443 on ClinicalTrials.gov